Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8651648rdf:typepubmed:Citationlld:pubmed
pubmed-article:8651648lifeskim:mentionsumls-concept:C0026848lld:lifeskim
pubmed-article:8651648lifeskim:mentionsumls-concept:C0085409lld:lifeskim
pubmed-article:8651648lifeskim:mentionsumls-concept:C0205202lld:lifeskim
pubmed-article:8651648pubmed:issue6lld:pubmed
pubmed-article:8651648pubmed:dateCreated1996-7-24lld:pubmed
pubmed-article:8651648pubmed:abstractTextA 35-year-old woman with features of Kearns-Sayre syndrome consisting of progressive ptosis, ophthalmoparesis, mitochondrial myopathy, and pigmentary retinopathy also had autoimmune polyglandular syndrome type 11 (Addison's disease, autoimmune insulin-dependent diabetes mellitus, Hashimoto's thyroiditis, and primary ovarian failure). There was no history of similarly affected relatives. Analysis of muscle mitochondrial DNA (mtDNA) revealed a 2,532-bp deletion of the type seen in Kearns-Sayre syndrome as well as a heteroplasmic A3243G mutation in the tRNA-Leu(UUR) gene of the type seen in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). The patient's blood and her mother's blood harbored the A3243G mutation but not the deletion, and the maternal grandmother's blood had neither mutation. In muscle, the species of mtDNA harboring the deletion was exclusively associated with the species harboring the A3243G mutation, suggesting that the point mutation predisposed to the large-scale deletion. The mtDNA species with both mutations accounted for 88% of total muscle mtDNA. Other and as yet unrecognized point mutations in mtDNA might also be associated with, and possible causally related to, large-scale mtDNA deletions.lld:pubmed
pubmed-article:8651648pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8651648pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8651648pubmed:languageenglld:pubmed
pubmed-article:8651648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8651648pubmed:citationSubsetIMlld:pubmed
pubmed-article:8651648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8651648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8651648pubmed:statusMEDLINElld:pubmed
pubmed-article:8651648pubmed:monthJunlld:pubmed
pubmed-article:8651648pubmed:issn0364-5134lld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:OhnoKKlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:YamamotoMMlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:FatourechiVVlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:HarperC MCMlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:EngelA GAGlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:SawF AFAlld:pubmed
pubmed-article:8651648pubmed:authorpubmed-author:RobertsL RLRlld:pubmed
pubmed-article:8651648pubmed:issnTypePrintlld:pubmed
pubmed-article:8651648pubmed:volume39lld:pubmed
pubmed-article:8651648pubmed:ownerNLMlld:pubmed
pubmed-article:8651648pubmed:authorsCompleteYlld:pubmed
pubmed-article:8651648pubmed:pagination761-6lld:pubmed
pubmed-article:8651648pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:meshHeadingpubmed-meshheading:8651648-...lld:pubmed
pubmed-article:8651648pubmed:year1996lld:pubmed
pubmed-article:8651648pubmed:articleTitleMELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy.lld:pubmed
pubmed-article:8651648pubmed:affiliationDepartment of Neurology and Muscle Research Laboratory, Mayo Clinic, Rochester, MN 55905, USA.lld:pubmed
pubmed-article:8651648pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8651648pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8651648pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8651648pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8651648lld:pubmed